Laura Fachal

14PUBLICATIONS
218CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Nanotoxicology, health and safetyGene mappingCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 03, 2026
Cell-type-resolved genetic variation shapes inflammatory bowel disease risk.

|May 25, 2026
Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

|Jul 16, 2025
Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease risk.

Tobi Alegbe, Bradley T Harris, Laura Fachal

|Jun 23, 2025
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts, Jaime Peters, Aleksejs Sazonvos

|Nov 06, 2024
Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci.

Elizabeth C Goode, Laura Fachal, Nikolaos Panousis

|Jan 18, 2022
A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis.

Line M H Schack, Elnaz Naderi, Laura Fachal

Pageof 3

Frequent Collaborators

4 joint publications

Alicja Wolk

4 joint publications

Douglas F Easton

4 joint publications

Carl A Anderson

4 joint publications

Børge G Nordestgaard